Biological ageing is not the same as chronological ageing. Your birth certificate records how many years you have lived. Your biology records how much cumulative oxidative stress, inflammation, and cellular damage has accumulated in that time. The two often diverge, and untreated sleep apnoea is one of the conditions that pushes them apart — moving your biological clock faster than the calendar.
This page covers three related areas: telomere length (the structural caps on chromosomes that reflect cellular ageing), epigenetic age acceleration (a newer and more powerful way of measuring biological age from DNA), and skin health. The evidence for each is distinct but mechanistically connected.
Telomeres: The Shoelace Tip Analogy
Telomeres are the protective caps at the ends of chromosomes — the structures in each cell's nucleus that contain the genetic blueprint. Each time a cell divides, the telomere shortens slightly. When telomeres become critically short, the cell loses its ability to divide further and enters a state called senescence — it stops functioning normally, produces inflammatory signals, and eventually undergoes programmed death. The rate at which telomeres shorten is one of the best established markers of biological ageing: people with shorter telomeres for their age have higher rates of age-related diseases and shorter life expectancy.
Think of telomeres like the plastic tips at the end of a shoelace. While they are intact, the lace works properly. As they wear down, the lace begins to fray. When they are gone, the structure underneath unravels. Oxidative stress — the cellular equivalent of rust — is one of the main drivers of accelerated telomere shortening. And intermittent nocturnal hypoxia from sleep apnoea generates substantial oxidative stress across every tissue of the body, every night.
A systematic review and meta-analysis covering multiple studies confirmed that OSA patients have significantly shorter telomeres than people of the same age without OSA. The effect size — expressed as an SMD, or standardised mean difference, which describes how far apart the two groups are in statistical terms — was -0.405. To translate that into practical terms: this is a small-to-medium effect, meaning OSA patients as a group register as biologically older than their same-age peers when measured by this particular molecular clock. The shortening is worse with more severe OSA, consistent with the more severe oxidative stress in those patients.
In children with sleep-disordered breathing, the telomere effect is already measurable — and arguably more concerning, because the shortening is occurring during the years when children are supposed to be at their biological peak. A meta-analysis found significantly shorter telomeres in children with OSA versus healthy controls (SMD -0.90), a medium-to-large effect that suggests the cellular ageing burden is proportionally substantial even at this age.
OSA patients have measurably shorter telomeres than people of the same age without the condition. Telomere length is one of the best available indicators of biological age, and the shortening worsens with OSA severity.
Epigenetic Age Acceleration
Epigenetics refers to changes in how genes are expressed — essentially, which parts of the genetic code are active — without altering the underlying DNA sequence itself. The pattern of a particular type of epigenetic modification called DNA methylation changes predictably as humans age, and researchers have used this pattern to construct what are called epigenetic clocks. These clocks can estimate biological age from a blood or saliva sample, and they predict health outcomes and mortality more accurately than chronological age does.
In OSA patients, epigenetic clocks consistently register an age that is older than the patient's actual chronological age. In plain terms: if you take a blood sample from a 50-year-old with untreated severe OSA and run it through an epigenetic clock analysis, the result is more likely to read as if they were 54 or 55. The discrepancy — the gap between biological and chronological age — is larger in patients with more severe OSA and with greater degrees of nocturnal oxygen desaturation.
This matters because epigenetic age acceleration is not merely a number. It predicts mortality, cardiovascular risk, cancer incidence, and cognitive decline independently of any other risk factors. A person who is biologically five years older than their chronological age, according to these clocks, carries the health risks of someone five years older, regardless of what is on their birth certificate.
The specific epigenetic changes in OSA patients overlap with those seen in heavy smokers and in people with chronic inflammatory conditions — both of which are known to accelerate biological ageing. This convergence of evidence from different methodologies provides stronger support for the conclusion that OSA causes genuine acceleration of the ageing process, not simply its appearance.
Skin Health and Appearance
The visible effects of untreated sleep apnoea on skin health are perhaps the most immediately concrete manifestation of this accelerated biology. The mechanisms are the same ones driving the systemic disease described elsewhere in this series: oxidative stress, systemic inflammation, endothelial dysfunction (impaired blood vessel response), and cortisol elevation. They simply manifest in the skin as well as in the arteries, brain, and liver.
Chronic intermittent hypoxia affects skin vascularity — the network of small blood vessels that supply the skin with oxygen and nutrients. Repeated oxygen drops alter the behaviour of these vessels in ways that impair the skin's ability to repair itself, maintain collagen production, and resist the cumulative damage of environmental stressors like UV radiation. The result is accelerated skin ageing: impaired skin barrier function, reduced elasticity, altered hydration, and diminished repair capacity after injury or sun exposure.
Growth hormone — which, as covered in the men's health section, is substantially suppressed in OSA patients — is one of the key signals for tissue repair in the skin. It drives collagen synthesis, promotes turnover of the skin cells, and supports the overnight repair processes that normally occur during deep sleep. When deep sleep is chronically disrupted by OSA and growth hormone pulses are suppressed, this repair process fails to complete night after night.
OSA is also associated with several specific dermatological conditions beyond general skin ageing. These include cutaneous T-cell lymphoma (a rare skin cancer), a skin condition called prurigo nodularis (where nodular, intensely itchy lesions develop on chronically scratched skin), and erythema nodosum (a painful inflammatory skin condition). The association with these conditions is thought to be mediated primarily through the systemic inflammation that severe OSA drives. The cancer connection here is consistent with the broader cancer evidence covered in the cancer risk page: systemic inflammation and nocturnal hypoxia create conditions that favour abnormal cell behaviour in every tissue including the skin.
Hair and Alopecia
The relationship between OSA and hair loss is an area where the evidence is emerging rather than definitive, but the biological logic is coherent. Chronic tissue hypoxia, reduced blood supply to hair follicles, elevated cortisol (which is directly toxic to hair follicle cycling), and suppressed growth hormone all represent mechanisms that could contribute to premature hair thinning or loss. The specific research on OSA and alopecia is limited, but the mechanistic overlap with conditions already known to cause hair loss — hormonal dysregulation, micronutrient absorption impairment, chronic stress physiology — is substantial enough to take seriously as a clinical hypothesis.
The Broader Picture of Accelerated Ageing
Taken together, the telomere shortening, epigenetic age acceleration, and skin changes described in this section represent converging evidence for what the mechanistic research would predict: that the chronic oxidative stress and inflammation from years of untreated sleep apnoea ages the body faster than it should be ageing.
This is not a peripheral or cosmetic concern. Biological age — as measured by epigenetic clocks, telomere length, and inflammatory markers — determines when and how severely age-related diseases manifest. A 55-year-old who is biologically 60 does not simply look five years older. They face the cardiovascular risks, cancer risks, and cognitive risks of a 60-year-old. The cumulative implications of this, across millions of people living with undiagnosed sleep apnoea, are substantial.
References
[1] Samareh Fekri M et al. Association between obstructive sleep apnea and telomere length: a systematic review and meta-analysis. Sleep and Breathing. 2020. 8 studies; adults with OSA have significantly shorter telomeres (SMD -0.405) compared with healthy controls; shortening correlated with OSA severity.
[2] Fan M et al. Association between sleep disorders and telomere length in children: a meta-analysis. Frontiers in Pediatrics. 2022. Meta-analysis; children with OSA had significantly shorter telomeres versus healthy controls (SMD -0.90, large effect size).
[3] Jin Q et al. Obstructive sleep apnea is associated with epigenetic age acceleration: evidence from two population-based cohorts. EBioMedicine. 2022. Large population cohorts; OSA patients showed significant epigenetic age acceleration on multiple epigenetic clock measures; acceleration correlated with ODI and AHI severity.
[4] Sunwoo HH et al. Obstructive sleep apnea and skin disorders: a bidirectional Mendelian randomization analysis. Skin Health and Disease. 2024. Bidirectional MR analysis; OSA causally associated with prurigo nodularis, cutaneous T-cell lymphoma, and erythema nodosum.
[5] Levy P et al. Intermittent hypoxia and pathophysiology of obstructive sleep apnea: oxidative stress, inflammation, and organ dysfunction. Respirology. 2024. Narrative review; mechanisms of oxidative stress in OSA — links to accelerated tissue ageing across multiple organ systems.
Contact Professor Vik Veer
If you would like to discuss a sleep assessment or arrange a consultation, please use the details below.
Private secretary: 0207 458 4584